Document is current
Any future updates will be listed below
-
Authors
Bernstein-Molho, Rinat https://orcid.org/0000-0002-4068-9514
Haisraely, Ory
Galper, Shira
Abu-Shhada, Narmeen
Nili Gal-Yam, Einav
Menes, Tehillah S.
Poortmans, Philip
Kaidar-Person, Orit
-
Funding
Funding for this research was provided by:
Tel Aviv University
- License Information
-
More Information
Article History
Received: 31 December 2024
Accepted: 15 February 2025
First Online: 5 March 2025
Declarations
:
: The authors disclose the following relationships/activities/interests (none related to the content of the manuscript): RBM: Honoraria for lectures from Astra Zeneca, Roche, Pfizer; Support for attending meetings from Pfizer (Inst), Gilead (Inst). OH: None; SG: None; NAS: None; ENGY: Honoraria: Roche, Pfizer, MSD, Lilly, AstraZeneca, Consulting or Advisory Role: MSD Oncology, AstraZeneca, Lilly, Travel, Accommodations, Expenses: Pfizer (Inst), Gilead Sciences (Inst); TSM: None; PP: None; OKP: None
: All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments and comparable ethical standards. IRB Approval No: SMC-21-8470 from 1/7/2021.
